openPR Logo
Press release

Global and U.S. Stimuli-responsive Drug Delivery Systems Market Report, Published by QY Research.

11-21-2025 12:33 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research

Global and U.S. Stimuli-responsive Drug Delivery Systems

A pharmaceutical company in Switzerland developing targeted cancer therapeutics struggled with severe dose-limiting toxicity and inconsistent drug distribution using conventional systemic formulations. Chemotherapy agents were dispersing throughout the body instead of concentrating at tumor sites, causing strong side effects and reducing treatment efficacy. To solve this, the R&D team adopted Stimuli-Responsive Drug Delivery Systems (SR-DDS) - smart nanocarriers that release active drugs only when triggered by specific internal or external stimuli such as pH change, enzymes, redox gradients, temperature, magnetic fields, or light. Using pH-responsive polymeric micelles designed to stay stable in the bloodstream but rapidly release payloads in the acidic tumor microenvironment (pH ≈ 6.5), the company achieved far higher local drug concentration, reduced systemic toxicity, and improved patient tolerance. Clinical trial data showed a 45% improvement in tumor inhibition with significantly fewer adverse reactions. SR-DDS are now critical in oncology, gene therapy, immunotherapy, controlled pain management, and personalized medicine.

https://www.qyresearch.com/reports/5183602/stimuli-responsive-drug-delivery-systems

Core Market Data

Global market size: USD 3.5 billion
CAGR (2024-2030): 9.1%
Average price: USD 1600 per unit
Annual production: 2.2 million units
Gross margin: 44%
Production capacity: 2.6 million units

List of Main Players

Camurus (Sweden)
EyePoint (USA)
Starpharma (Australia)
Nanobiotix (France)
Taiwan Liposome (Taiwan)
NanoCarrier (Japan)
Celsion (USA)
OxSonics (UK)
Insightec (Israel)
CarThera (France)
PCI Biotech (Norway)
EnGeneIC (Australia)
InnoMedica (Switzerland)
InCephalo (Switzerland)
BioArctic (Sweden)
Acuitas (Canada)
Nanexa (Sweden)
PolyActiva (Australia)
GP Pharm (Spain)
Bionaut Labs (USA)

1. By Stimulus Type

Internal Stimuli-Responsive Systems
External Stimuli-Responsive Systems
Multi-Stimuli-Responsive Systems

2. By Carrier Platform

Polymeric Nanoparticles
Liposomes & Lipid Nanocarriers
Hydrogels & Nanogels
Dendrimers
Inorganic Nanocarriers (Gold, Silica, Iron Oxide)
Stimuli-sensitive Micelles

3. By Therapeutic Application

Oncology (Chemotherapy, Immunotherapy)
Diabetes & Metabolic Diseases
Inflammation Control & Pain Management
Neurological Disorders
Infectious Diseases
Regenerative Medicine

4. By End-Use Sector

Pharmaceutical Companies
Healthcare Providers
Contract Manufacturing Organizations

Case Study for Bidding

Time: April 2024
Supplier: Evonik Industries AG (Germany)
Buyer: Novartis (Switzerland)
Product: pH-responsive polymeric nanoparticle delivery systems for targeted oncology therapy
Quantity: 12,500 units
Contract Value: USD 28 million
Delivery Timeline: December 2025

Case Study for End Using

End User: Massachusetts General Hospital (U.S.)

Application: Used in targeted chemotherapy trials for solid tumors using enzyme-responsive nanocarriers.

Installation Location

Administered through intravenous infusion in controlled clinical settings.
Nanocarriers accumulate in tumor microenvironments via EPR effect (enhanced permeability and retention).
Activated by tumor-specific enzyme concentrations for local drug release.

Purpose

Reduces systemic toxicity of traditional chemotherapy drugs.
Delivers high concentrations of therapeutics directly to cancerous tissues.
Improves clinical safety profiles for next-generation oncology treatments.

Effect

Increased tumoral drug accumulation by 42%.
Reduced off-target toxicity complications by 33%.
Improved patient response rates in early-phase trials.

Alternative Devices

Conventional polymer or liposomal carriers deliver drugs systemically but cannot release therapeutics specifically in response to environmental or physical triggers.
Therefore, Stimuli-Responsive Drug Delivery Systems remain essential for precision medicine, controlled release, and next-generation therapeutic strategies.

About QY Research

QY Research has established close partnerships with over 71,000 global leading players. With more than 20,000 industry experts worldwide, we maintain a strong global network to efficiently gather insights and raw data.

Our 36-step verification system ensures the reliability and quality of our data. With over 2 million reports, we have become the world's largest market report vendor. Our global database spans more than 2,000 sources and covers data from most countries, including import and export details.

We have partners in over 160 countries, providing comprehensive coverage of both sales and research networks. A 90% client return rate and long-term cooperation with key partners demonstrate the high level of service and quality QY Research delivers.

More than 30 IPOs and over 5,000 global media outlets and major corporations have used our data, solidifying QY Research as a global leader in data supply. We are committed to delivering services that exceed both client and societal expectations.

For Inquiries:

USA: +1-626-295-2442

Canada: +1-778-907-6631

China: +86-150-1303-8387

Japan: +81-90-3800-9273

South Korea: +82-2883-1278

India: +91-866-9986-909

Indonesia: +62-818-510-991

Germany: +49-15788468916

Switzerland: +41-765899438

Portugal: +351-910983247

Email: global@qyresearch.com

www.qyresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global and U.S. Stimuli-responsive Drug Delivery Systems Market Report, Published by QY Research. here

News-ID: 4281103 • Views:

More Releases from QY Research

Global and U.S. Soil Testers Market Report, Published by QY Research.
Global and U.S. Soil Testers Market Report, Published by QY Research.
QY Research has released a comprehensive new market report on Soil Testers, providing an in-depth analysis of global demand, key manufacturers, product segmentation, technological trends, pricing structures, and regional market dynamics. The report delivers strategic insights for suppliers, investors, and end users evaluating growth opportunities in the soil testing instrumentation industry. https://www.qyresearch.com/reports/5541278/soil-testers Core Market Data Global market size: USD 750 million CAGR (2024-2030): 5.3% Average price: USD 50 per unit Annual production: 15 million units Gross margin:
Top 30 Indonesian Mining Public Companies Q3 2025 Revenue & Performance
1) Overall companies performance (Q3 2025 snapshot) This curated list (below) is drawn from IDX/market summaries of listed mining sector issuers (companies active in coal, nickel, copper, gold, tin, bauxite, integrated miners and mining services). Many of these companies published Q3/9M 2025 financials in OctNov 2025/. Adaro Energy (ADRO); PT Bukit Asam (PTBA); Bayan Resources (BYAN); Indo Tambangraya Megah (ITMG); PT Aneka Tambang / Antam (ANTM); Vale Indonesia (INCO); PT Timah (TINS);
Inside the USD 18.4 Billion PE Jar Boom: Asias Surge, Indonesias EPR Push, and the Next Wave of Packaging Innovation
Inside the USD 18.4 Billion PE Jar Boom: Asias Surge, Indonesias EPR Push, and t …
The polyethylene (PE) plastic jar packaging sector is a foundational segment of rigid plastic packaging that serves food & beverage, personal care, cosmetics, household chemicals and pharmaceuticals. As brands chase low-cost, lightweight, and recyclable primary packaging while responding to tighter sustainability rules and shifting consumer expectations, PE jars remain a common choice because of their cost-effectiveness, material versatility and broad tooling base. This report examines the industry structure, current dynamics,
The Global Melatonin Market Revealed: Profit Margins, Industry Shifts, and Asias Expanding Manufacturing Might
The Global Melatonin Market Revealed: Profit Margins, Industry Shifts, and Asias …
The global melatonin market has become a high-growth segment within APIs ingredients as demand for sleep-health solutions, chronobiology-enabled therapeutics and related nutraceuticals expands. This report uses the market baseline you provided as the core forecast anchor and combines that brief with public market and price signals, regional production intelligence and recent industry news to produce a pragmatic, investor-oriented brief focused on Asia and Southeast Asia. Melatonin is produced and sold

All 5 Releases


More Releases for Delivery

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period." Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research. The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth. The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically